CPhI Pharma Awards honor companies and individuals driving the pharma industry forward.
Recipients of the 14th annual 2017 CPhI Pharma Awards were announced on Oct. 24, 2017 at an awards ceremony at the CPhI Worldwide trade show in Frankfurt, Germany. More than 200 entries were received in 2017-twice the number of entries in 2016-and included innovations in products and services for drug formulation, development, manufacturing, drug delivery, packaging, and distribution. In addition, bio/pharma executives and companies were honored for their business, scientific, and social contributions.
The awards were expanded to nearly 20 categories for 2017 to reflect the increased diversity of attendees at CPhI Worldwide, the organizers report. Separate awards were presented for innovation in formulation and excipients. New categories recognized sustainability practices, export promotion, over-the-counter drugs, patient centricity, and IT, mHealth, and digitalization.
The entries were reviewed by a panel of independent judges from pharma, industry suppliers, testing labs, and the media, including BioPharm International. A list of finalists was announced in September 2017. The winners were revealed during a gala awards ceremony.
The 2017 CPhI Pharma Award recipients are as follows:
Analysis, Testing, and Quality Control-FlexiQuot: New disruptive technology that revolutionizes sample storage and handling, 1CryoBio
API Development--Development of a new, efficient synthesis of ospemifene, Cambrex
Bioprocessing-Modular automated sampling technology (MAST) platform for the biopharma industry, Capsugel/Bend Research (Lonza)
CEO of the Year-Richard Chin, CEO of KindredBio
Contract Services and Outsourcing-Modified supercritical anti-solvent (mSAS) technology for accelerated product development, Crystec Ltd.
Corporate Social Responsibility-HepC battle, Laboratories Pharma5
Drug Delivery Devices-Single-use inhaler (DPI) Perlamed-BLISTair, Perlen Packaging
Excipients-Opadry QX for tablet film coating, Colorcon
Export Promotion-Waste water treatment plants, Rachana Overseas Inc.
Formulation-Orbis’ Optimum Platform: Delivering dispersed dosage forms with functional coatings in a single manufacturing step, Orbis Biosciences
IT, mHealth, and Digitilization-Biocorp’s line of connected products, Biocorp
Manufacturing Technology and Equipment-MicroJet Reactor technology with efficient control on particle size and homogeneity of particle size distribution, MJR PharmJet
OTC-Innovation in wart treatment, Pronova Laboratories
Packaging-Side actuation device: Innovation in ophthalmic drug-delivery devices, Aero Pump GmbH
Patient Centricity-Target My Hives, ERT
Pharma Company of the Year, SME-BenevolentAI
Regulatory Procedures and Compliance-Quality and Regulatory-A Means for Value Creation, Piramal Enterprises
Supply Chain, Logistics, and Distribution-Industry’s first compliance and digital information platform for the EU Falsified Medicines Directive, TraceLink
Sustainability Initiative of the Year-AptarGroup’s Landfill Free Certification: promoting efficiencies and the conservation of natural resources in a global manufacturing setting, AptarGroup.
The editors congratulate the awards finalists and winners. Additional information about the winning technologies will be published in future issues of BioPharm International and on www.biopharminternational.com.
CPhI and BioPharm International are UBM plc brands.
BioPharm International
Volume 30, Number 11
November 2017
Page: 6
When referring to this article, please cite it as R. Peters, “Awards Recognize Bio/Pharma Industry Contributions," BioPharm International 30 (11) 2017.